in an attempt to minimize the immune response of these patients to the administered murine monoclonal antibody , we developed a recombinant form of the murine b72.3 as well as a recombinant/chimeric antibody , using the variable regions of the murine b72.3 and human heavy chain ( gamma 4 ) and light chain ( kappa ) constant regions .
C0086418
human
C1420192
heavy chain